Natural History of Five Children With Surfactant Protein C Mutations and Interstitial Lung Disease

被引:60
作者
Avital, Avraham [1 ]
Hevroni, Avigdor [1 ]
Godfrey, Simon [1 ]
Cohen, Shlomo [1 ]
Maayan, Channa [1 ]
Nusair, Samir [1 ]
Nogee, Lawrence M. [2 ]
Springer, Chaim [1 ]
机构
[1] Hadassah Univ Hosp Ein Kerem, Inst Pulmonol, Jerusalem, Israel
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neonatol, Baltimore, MD 21205 USA
关键词
SFTPC; ILD; pediatric; chloroquine; CHLOROQUINE TREATMENT; FIBROSING ALVEOLITIS; HUMAN FIBROBLASTS; ABCA3; MUTATIONS; PNEUMONITIS; DEFICIENCY;
D O I
10.1002/ppul.22971
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Interstitial lung diseases in infants and children are uncommon and may be caused by specific inborn errors of surfactant metabolism. Five children with open lung biopsy diagnosed interstitial lung disease were followed (mean of 27.2 years) and evaluated for surfactant protein gene mutations. Four of the children were originally diagnosed as desquamative interstitial pneumonitis and one as chronic interstitial pneumonitis. All had good response to chloroquine or hydroxychloroquine treatment for periods of 7-38 months. Lung function tests, incremental exercise tests, and rentgenological studies were performed in the children. Surfactant protein gene mutations were searched in all the patients and in part of their families. Three of the patients, aged now 32, 29, and 37 years, feel well and have normal lung function, while two of the patients, both females, aged 28 and 37 years, conduct normal activities of daily living, have healthy children but have clinical, physiological and rentgenological evidence of restrictive lung disease. All five patients were found to have surfactant protein C gene (SFTPC) mutations, three of them with the most common mutation (p.I73T) and the other two with new mutations of surfactant protein C gene (p.I38F and p.V39L). We conclude that detection of surfactant protein mutations should be attempted in all children presenting with interstitial lung disease. Furthermore, treatment with hydroxychloroquine should be considered in children with SFTPC mutations. Prospective evaluation of hydroxychloroquine therapy in a greater number of patients is needed. Pediatr Pulmonol. 2014; 49:1097-1105. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:1097 / 1105
页数:9
相关论文
共 40 条
  • [1] CHLOROQUINE TREATMENT OF INTERSTITIAL LUNG-DISEASE IN CHILDREN
    AVITAL, A
    GODFREY, S
    MAAYAN, C
    DIAMANT, Y
    SPRINGER, C
    [J]. PEDIATRIC PULMONOLOGY, 1994, 18 (06) : 356 - 360
  • [2] Balasubramanyan N, 1997, PEDIATR PULM, V23, P55, DOI 10.1002/(SICI)1099-0496(199701)23:1<55::AID-PPUL7>3.0.CO
  • [3] 2-O
  • [4] BARNETT HL, 1972, PEDIATRICS, P1315
  • [5] Buchino J J, 1987, Am J Med Genet Suppl, V3, P285
  • [6] A common mutation in the surfactant protein C gene associated with lung disease
    Cameron, HS
    Somaschini, M
    Carrera, P
    Hamvas, A
    Whitsett, JA
    Wert, SE
    Deutsch, G
    Nogee, LM
    [J]. JOURNAL OF PEDIATRICS, 2005, 146 (03) : 370 - 375
  • [7] CARRINGTON CB, 1978, NEW ENGL J MED, V298, P801, DOI 10.1056/NEJM197804132981501
  • [8] Clinical, radiological and pathological features of ABCA3 mutations in children
    Doan, M. L.
    Guillerman, R. P.
    Dishop, M. K.
    Nogee, L. M.
    Langston, C.
    Mallory, G. B.
    Sockrider, M. M.
    Fan, L. L.
    [J]. THORAX, 2008, 63 (04) : 366 - 373
  • [9] The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model
    Donohue, Elizabeth
    Thomas, Anitha
    Maurer, Norbert
    Manisali, Irina
    Zeisser-Labouebe, Magali
    Zisman, Natalia
    Anderson, Hilary J.
    Ng, Sylvia S. W.
    Webb, Murray
    Bally, Marcel
    Roberge, Michel
    [J]. JOURNAL OF CANCER, 2013, 4 (07): : 585 - 596
  • [10] Fan Leland L., 1994, Current Opinion in Pediatrics, V6, P248, DOI 10.1097/00008480-199406000-00004